Dexmedetomidine combined with Maniac Mengxing Decoction acupoint sticking in elderly patients

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2300068774

Enrollment

Unknown

Registered

2023-02-28

Start date

2023-03-01

Completion date

Unknown

Last updated

2023-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

delirium

Interventions

Conventional + dexmedetomidine intervention group:Conventional + dexmedetomidine intervention

Routine + dexmedetomidine combined with maniacal awakening acupoint paste intervention group:Routine + dexmedetomidine combined with maniacal awakening acupoint paste intervention

Conventional treatment group:Conventional treatment

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Inclusion criteria: age >65; Patients without delirium before operation; There was no history of long-term use of sedative drugs before surgery. Have complete cases and go to the hospital for review on time. Approved by the ethics committee of the hospital, patients and their families signed informed consent forms.

Exclusion criteria

Exclusion criteria: History of dementia

Design outcomes

Primary

Measure	Time frame
Delirium or not;	—

Secondary

Measure	Time frame
pain degree;sleep quality;mental state;memory ability;	—

Countries

China

Contacts

Public ContactYuan Yuan

Gansu Provincial People's Hospital

lanzhouyy@163.com18919961203

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026